Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Reunion Neuroscience Inc T.REUN

Reunion Neuroscience Inc. is engaged in the psychedelic drug development company that provides therapeutic solutions for mental health conditions by developing serotonin receptor agonist compounds. The Company is developing the advancement of synthetic molecules targeting serotonin 5HT2A receptors. The Company’s products include RE104 and RE200. The Company’s lead asset, RE-104, which is a... see more

Recent & Breaking News (TSX:REUN)

Field Trip Health Ltd. to Participate in Upcoming Conferences in November 2021

GlobeNewswire November 3, 2021

Field Trip Health (TSX:FTRP) schedules Q2 financial results conference call

John Ballem  November 2, 2021

Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, November 16, 2021 at 8:30 AM ET

GlobeNewswire November 2, 2021

Field Trip Health (TSX:FTRP) announces three new therapy centers

Trevor Abes  October 19, 2021

Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton

GlobeNewswire October 19, 2021

Field Trip Health Ltd. To Present At The KCSA Psychedelics Virtual Investor Conference On October 13th

PR Newswire October 12, 2021

Field Trip Health announces voting results from AGM

Stockhouse Editorial September 27, 2021

Field Trip Health Announces Voting Results From the Annual General and Special Meeting of Shareholders

GlobeNewswire September 24, 2021

Field Trip Health (TSX:FTRP) to participate in four upcoming investor conferences

John Ballem  September 10, 2021

Field Trip Health Ltd. to Participate in Four Investor Conferences in September

GlobeNewswire September 10, 2021

Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104

GlobeNewswire September 9, 2021

Toronto Stock Exchange, Field Trip Health Ltd., C-Suite at The Open

PR Newswire September 1, 2021

Field Trip Health (TSX:FTRP) launches KAP Co-operative Program

Trevor Abes  August 31, 2021

Field Trip Health Ltd. Announces Launch Of "Kap Co-Operative" Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers; Also Launches Training Programs To Educate A New Generation Of Psychedelic Clinicians

GlobeNewswire August 31, 2021

Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results

GlobeNewswire August 16, 2021

Field Trip Health Ltd. Schedules First Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, August 17, 2021 at 8:30 am ET

GlobeNewswire August 10, 2021

Field Trip Health (TSX:FTRP) to begin trading on the NASDAQ

John Ballem  July 27, 2021

Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP

GlobeNewswire July 27, 2021

Field Trip Health (TSX:FTRP) obtains conditional approval to list on the NASDAQ

Trevor Abes  July 23, 2021

Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol "FTRP"

GlobeNewswire July 23, 2021